Status:
COMPLETED
Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital
Lead Sponsor:
Instituto do Cancer do Estado de São Paulo
Conditions:
Postoperative Nausea
Postoperative Vomiting
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Previous history of nausea and vomiting induced by prior chemotherapy still not included as predictive factor of postoperative nausea and vomiting, although has been demonstrated that has influence in...
Detailed Description
Quasi-experimental study, with evaluation after the application of a specific postoperative nausea and vomiting prevention algorithm for cancer patients. The study will be carried out in 2 phases: P...
Eligibility Criteria
Inclusion
- All patients who underwent medium to large surgery
Exclusion
- Patients who are unable to communicate (orotracheal intubation after the surgery, confusion or agitation) or understand the Portuguese language;
- Insulin dependent patients
- Patients who underwent emergency surgery and neurosurgery
- Pacients who had an increased QT interval on the electrocardiogram
- History of allergy to dexametasone, ondansetron or droperidol
- Refusal to participate
Key Trial Info
Start Date :
February 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2021
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT04411069
Start Date
February 20 2019
End Date
March 20 2021
Last Update
May 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Institute of the State of Sao Paulo - ICESP
São Paulo, São Paulo, Brazil, 01403010